KDR-5169

N/A

Report date: 2023/10/12 15:27:08
NME

Base Information

Drug NameKDR-5169
Drug Alias NameKDR-5169
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 4 (5-HT4) receptor agonistsDopamine D2 receptor antagonists
TargetsSerotonin 4 (5-HT4) receptorDopamine D2 receptor
Therapy Area/IndicationsGastroparesis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsGastroparesis

Other Information

ATC CodeN/A
Related LinksN/A